## KEYS: Keysight Technologies, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 0.6% below STRENGTH zone (4.0-10.0%); PEG 1.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (56% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($197.75)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Calamos Advisors LLC Has $10 Million Position in Keysight Technologies Inc. $KEYS**
- Source: MarketBeat | 20260101T101426 | Bullish | Relevance: 100%
- Calamos Advisors LLC significantly increased its stake in Keysight Technologies Inc. (NYSE:KEYS) by 19.5% in the third quarter, bringing their total holdings to $9.999 million. This comes as Keysight reported strong Q3 earnings, beating analyst estimates, and announced a $1.5 billion share buyback program. The company maintains a "Moderate Buy" rating from analysts with an average price target of $218.82, while institutional ownership stands at 84.58%.

**2. Keysight Technologies Inc. (NYSE:KEYS) Given Average Recommendation of "Moderate Buy" by Analysts**
- Source: MarketBeat | 20260101T061935 | Somewhat-Bullish | Relevance: 100%
- Keysight Technologies Inc. (NYSE:KEYS) has received a "Moderate Buy" consensus rating from analysts, with an average 1-year price target of $218.82. The company recently surpassed quarterly earnings and revenue expectations, reporting 10.1% year-over-year revenue growth. Keysight also authorized a $1.5 billion share repurchase plan, and while insiders sold stock recently, they still own about 0.61% of the company.

**3. ImSym - Imaging System Simulator**
- Source: Photonics Spectra | 20260102T150547 | Bullish | Relevance: 100%
- Keysight Technologies Inc. introduces ImSym, an imaging system simulator designed to streamline product development. This tool provides an end-to-end model of imaging systems, including lenses, sensors, and image and signal processors (ISPs), enabling precise visualization and quantitative data analysis before manufacturing. ImSym aims to accelerate the delivery of new imaging products to market.

**4. Fenimore Asset Management Inc Buys 6,629 Shares of Keysight Technologies Inc. $KEYS**
- Source: MarketBeat | 20260101T101826 | Somewhat-Bullish | Relevance: 99%
- Fenimore Asset Management Inc increased its stake in Keysight Technologies Inc. by 1.1% in the third quarter, purchasing 6,629 additional shares to hold a total of 632,432 shares. This makes Keysight Technologies the 16th-largest position in Fenimore's portfolio, representing approximately 2.2% of its total holdings. The article also notes Keysight's strong Q3 earnings, positive Q1 2026 guidance, a $1.5 billion stock repurchase authorization, and recent insider selling activities.

**5. Fortive Corp.: The Quiet Infrastructure Platform Powering the Next Industrial Upgrade**
- Source: AD HOC NEWS | 20260101T040819 | Neutral | Relevance: 67%
- Fortive Corp. has transformed from an industrial roll-up into a data-driven instrumentation and software platform, leveraging its operating system and diverse portfolio to digitize industries. The company focuses on measurement, workflow, and reliability across Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions segments. Fortive's strategic shift towards recurring revenue and software-first solutions positions it as a significant player in the industrial tech and SaaS hybrid market.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $227 | $208 | +9% |
| 2025-12-10 | Jefferies | $220 | $195 | +13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-10 | Jefferies | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.00M) |
| Sells | 50 ($17.43M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.5% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.5%)
- Price (T.Rowe) Assoc: 10.1% (-8.6%)
- Blackrock Inc.: 9.8% (+1.9%)
- State Street Corpora: 4.7% (+0.2%)
- Geode Capital Manage: 3.0% (+12.7%)

### Key Risks

1. Heavy insider selling: $17M sold (50 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +1.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.56 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (2.4x). Analyst sentiment positive (2 raises, avg +11%). Insider selling cluster ($17.4M in 90 days), potential headwind.

| Metric | Value |
|--------|-------|
| Market Cap | $35.5B |
| Beta | 1.20 |
| 52W Range | $121.43 - $214.58 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.56 |
| Forward P/E | 22.3 |
| Current P/E | 25.5 |
| YoY Growth | 14.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.7% to 0.6% (+1.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >4.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.23x) but short-term weakness (below SMA20). MACD histogram bearish (-1.06), momentum weakening. RSI neutral at 59. Volume at 56% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.59% (CS: 48) | Neutral |
| RSI_14 | 59.4 | Neutral |
| MACD Histogram | -1.06 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 1.230x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $206.59
- **Stop Loss:** $197.75 (4.3% risk)
- **Target:** $215.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 135
- **Position Value:** $27,889.65
- **Portfolio %:** 27.89%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-24 (Est: $1.99)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.83 | $1.91 | +4.2% |
| 2025Q3 | $1.67 | $1.72 | +2.9% |
| 2025Q2 | $1.65 | $1.70 | +3.3% |
| 2025Q1 | $1.69 | $1.82 | +7.6% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*